Inventor · disambiguated record
Gerald Juergen Roth
Also filed as: ROTH GERALD · ROTH GERALD J · ROTH GERALD JUERGEN
45 granted patents·24 pending applications·434 citations·filing 2000–2023
98Inventor score
Files withBOEHRINGER INGELHEIM INT28BOEHRINGER INGELHEIM PHARMA19FLECK MARTIN5ROTH GERALD JUERGEN5PARK JOHN EDWARD3
Top patents by PatentIndex Score
69 records- 0197US6762180B1Substituted indolines which inhibit receptor tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Jul 13, 2004·129 cites·8 claims
- 0296US10154990B2Medicaments for the treatment or prevention of fibrotic diseasesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Dec 18, 2018·15 cites·5 claims
- 0396US7547703B2Indoline derivatives substituted in the 6-position, their preparation and their use as medicamentsBOEHRINGER INGELHEIM PHARMA·Filed 2006·Granted Jun 16, 2009·28 cites·9 claims
- 0491US7119093B23-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical compositionBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Oct 10, 2006·41 cites·7 claims
- 0591US6794395B1Substituted indolinones, their manufacture and their use as medicamentsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Sep 21, 2004·29 cites·8 claims
- 0688US8623860B2Azetidine derivatives, pharmaceutical compositions and uses thereofFLECK MARTIN·Filed 2012·Granted Jan 7, 2014·17 cites·10 claims
- 0788US7989474B2Use of Lck inhibitors for treatment of immunologic diseasesBOEHRINGER INGELHEIM PHARMA·Filed 2008·Granted Aug 2, 2011·14 cites·2 claims
- 0887US11104665B2PyridazinesBOEHRINGER INGELHEIM INT·Filed 2019·Granted Aug 31, 2021·5 cites·31 claims
- 0985US8067590B2Pyridone derivates with MCH antagonistic activity and medicaments comprising these compoundsSTENKAMP DIRK·Filed 2007·Granted Nov 29, 2011·9 cites·12 claims
- 1085US7176231B2Aryl-containing 5-acylindolinones, the preparation thereof and their use as medicamentsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Feb 13, 2007·10 cites·11 claims
- 1185US2023372297A1Medicaments for the treatment or prevention of fibrotic diseasesBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1284US6638965B2Substituted indolinones, preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Oct 28, 2003·13 cites·13 claims
- 1383US11485727B2N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulatorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Nov 1, 2022·1 cites·28 claims
- 1483US7148249B2Indolinones substituted by heterocycles, the preparation thereof and their use as medicamentsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Dec 12, 2006·21 cites·7 claims
- 1582US7592373B2Amide compounds with MCH antagonistic activity and medicaments comprising these compoundsBOEHRINGER INGELHEIM INT·Filed 2004·Granted Sep 22, 2009·13 cites·18 claims
- 1681US7351719B2Amide compounds having MCH-antagonistic activity and medicaments comprising these compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Apr 1, 2008·16 cites·17 claims
- 1779US6855710B2Substituted indolines with an inhibitory effect on various kinases and complexes of CDKsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Feb 15, 2005·14 cites·9 claims
- 1878US7560480B2Alkyl-containing 5-acylindolinones, the preparation thereof and their use as medicamentsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Jul 14, 2009·4 cites·11 claims
- 1977US7605176B2β-ketoamide compounds with MCH antagonistic activityBOEHRINGER INGELHEIM INT·Filed 2005·Granted Oct 20, 2009·2 cites·18 claims
- 2077US7452911B2Alkyne compounds with MCH antagonistic activity and medicaments comprising these compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Nov 18, 2008·10 cites·17 claims
- 2177US7169936B2Indolinone derivatives substituted in the 6-position, their preparation and their use as medicamentsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jan 30, 2007·6 cites·4 claims
- 2277US2010204211A1Medicaments for the treatment or prevention of fibrotic diseasesBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 2376US8835472B2Compounds, pharmaceutical compositions and uses thereofROTH GERALD JUERGEN·Filed 2011·Granted Sep 16, 2014·4 cites·8 claims
- 2476US7160901B2Substituted indolinones, preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jan 9, 2007·6 cites·13 claims
- 2575US8618132B2Alkyne compounds with MCH antagonistic activity and medicaments comprising these compoundsSTENKAMP DIRK·Filed 2008·Granted Dec 31, 2013·3 cites·8 claims
- 2675US6858641B2Substituted indolinonesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Feb 22, 2005·9 cites·9 claims
- 2774US7592358B2Alkyne compounds with MCH antagonistic activity and medicaments comprising these compoundsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Sep 22, 2009·2 cites·18 claims
- 2873US7524862B2Alkyne compounds with MCH antagonistic activity and medicaments comprising these compoundsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Apr 28, 2009·1 cites·27 claims
- 2972US9006450B2Compounds, pharmaceutical compositions and uses thereofROTH GERALD JUERGEN·Filed 2011·Granted Apr 14, 2015·3 cites·9 claims
- 3072US2019038600A1Medicaments for the treatment or prevention of fibrotic deiseasesBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 3171US9340507B2Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activityBOEHRINGER INGELHEIM INT·Filed 2015·Granted May 17, 2016·1 cites·2 claims
- 3271US2023100516A1PyridazinesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 3371US2020330435A1Medicaments for the treatment or prevention of fibrotic diseasesBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 3469US8877754B2Compounds, pharmaceutical compositions and uses thereofROTH GERALD JUERGEN·Filed 2011·Granted Nov 4, 2014·2 cites·10 claims
- 3569US7166615B2Substituted indolinones, preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jan 23, 2007·3 cites·10 claims
- 3669US2014296217A1Medicaments for the treatment or prevention of fibrotic diseasesPARK JOHN EDWARD·Filed 2014·Application pending·0 cites
- 3768US7858616B2Indolinone derivatives substituted in the 6 position, their preparation and their use as medicamentsBOEHRINGER INGELHEIM PHARMA·Filed 2009·Granted Dec 28, 2010·0 cites·4 claims
- 3867US9340510B2Tetrahydroisoquinoline derivatives, pharmaceutical compositions and uses thereofBOEHRINGER INGELHEIM INT·Filed 2015·Granted May 17, 2016·1 cites·11 claims
- 3967US2023022770A1Novel pyridazinesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 4066US9169205B2Pyrrolidine derivatives, pharmaceutical compositions and uses thereofFLECK MARTIN·Filed 2013·Granted Oct 27, 2015·1 cites·14 claims
- 4166US8877741B2Pyrrolidine derivatives, pharmaceutical compositions and uses thereofFLECK MARTIN·Filed 2014·Granted Nov 4, 2014·1 cites·14 claims
- 4266US2006142373A1Medicaments for the Treatment or Prevention of Fibrotic DiseasesBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 4364US11465982B2PyridazinesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Oct 11, 2022·0 cites·28 claims
- 4462US12391667B2N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as Autotaxin (ATX) modulators for the treatment of inflammatory airway or fibrotic diseasesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Aug 19, 2025·0 cites·3 claims
- 4561US2009306104A1Use of Lck inhibitors for treatment of immunologic diseasesBOEHRINGER INGELHEIM PHARMA·Filed 2009·Application pending·0 cites
- 4656US2009048267A1Medicaments for the treatment or prevention of fibrotic diseasesBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 4755US2014128409A1Medicaments for the treatment or prevention of fibrotic diseasesPARK JOHN EDWARD·Filed 2014·Application pending·0 cites
- 4853US2006148883A1Medicaments for the Treatment or Prevention of Fibrotic DiseasesBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 4953US2004204458A1Use of Lck inhibitors for treatment of immunologic diseasesBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 5052US2006258681A13-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical compositionROTH GERALD J·Filed 2006·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gerald Juergen Roth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →